Investment in research to tackle poverty-related and neglected diseases – such as TB and malaria – has fallen since the COVID-19 pandemic, according to Andrew Tuttle, chief strategy officer of Policy Cures Research. After rising steadily, annual investment in such research began to plateau in 2018 and then declined in the wake of the pandemic, he told a session entitled Deepening cooperation with the Global South for sustainable health futures at the Science|Business Annual Conference, organised in partner